Healthcare Industry News: Surgisis Biodesign
News Release - February 11, 2008
Cook Medical Introduces Umbilical Hernia Graft Designed to Fit Individual Patient Anatomies
Company's Biodesign Technology Offers Patients a Unique Treatment for Umbilical HerniasBLOOMINGTON, Ind.--(HSMN NewsFeed)--Cook Medical has released the Surgisis Biodesign™ Umbilical Hernia Graft, a unique solution for umbilical hernia repair that incorporates the company’s breakthrough Surgisis Biodesign technology. The new treatment is designed specifically to fit the individual anatomy of a patient.
The Surgisis Biodesign Umbilical Hernia Graft incorporates the best attributes of a biologic graft – resistance to infection and complete remodeling – with the added benefits of moderate price, ease of use and widespread availability. The distinct design provides patients with a tailored treatment that helps create functional, living tissue, and restores the natural form and function of the body. As a result, patients experience a quick and efficient recovery period, and typically return to their normal, daily activities within two to three weeks after surgery.
Additionally, the Surgisis Biodesign Umbilical Hernia Graft boasts a unique hole pattern along the periphery of the graft, which provides surgeons with additional guidance for suture placement. The fast-hydrating material has a shelf life of 18 months, requires no refrigeration and is ready to suture within five minutes.
Umbilical hernias occur when part of the intestine protrudes through a weak spot in the abdominal muscles at the navel. The bulge typically ranges from one to five centimeters in diameter. Although painless in children and infants, umbilical hernias that appear during adulthood can cause severe abdominal discomfort. Umbilical hernias can be caused by obesity, heavy lifting, coughing, multiple pregnancies and fluid in the abdominal cavity.
“Our latest addition to the Surgisis Biodesign family clearly demonstrates our dedication and commitment to medical innovation,” said Andy Cron, vice president of Cook Medical’s surgery strategic business unit of Cook Medical. “Umbilical hernias affect thousands of Americans each year, from infants to seniors. The Surgisis Biodesign Umbilical Hernia Graft addresses the individual and unique needs of each patient, and provides each patient with a safe, effective and lasting repair to a common and painful condition.”
Cook Medical’s Surgisis Biodesign product line provides unique treatments for several procedural areas, including hernia repair, fistula repair, plastic & reconstructive/ENT, staple line reinforcement, Peyronie’s repair, continence restoration, dural repair and pelvic floor repair.
About Cook Medical
Cook Medical was one of the first companies to introduce interventional devices in the United States. Today, the company participates in all global markets, integrating device design, biopharma, gene and cell therapy and biotech to enhance patient safety and improve clinical outcomes. Cook won the prestigious Medical Device Manufacturer of the Year from Medical Device and Diagnostic Industry magazine. For more information, visit www.cookmedical.com.
Source: Cook Medical
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
